Legal & General Group Plc Reduces Stake in ResMed Inc.

The institutional investor sold over 13,000 shares of the medical equipment provider's stock.

Mar. 12, 2026 at 10:21am

Got story updates? Submit your updates here. ›

Legal & General Group Plc, a major institutional investor, reduced its stake in ResMed Inc. (NYSE:RMD) by 1.4% during the third quarter. The firm now owns 958,210 shares of the medical equipment provider's stock, valued at $262,291,000, after selling 13,257 shares.

Why it matters

ResMed is a leading manufacturer of medical devices for the treatment of sleep-disordered breathing and other respiratory conditions. The company's products are widely used in the healthcare industry, and changes in major institutional ownership can signal shifts in investor sentiment and market expectations.

The details

According to the SEC filing, Legal & General Group Plc sold 13,257 shares of ResMed stock during the third quarter. The firm now owns approximately 0.66% of the company's outstanding shares. Several other large investors have also recently adjusted their positions in ResMed, with some increasing their stakes and others, like Legal & General, reducing exposure.

  • The stake reduction occurred during the third quarter of the year.

The players

Legal & General Group Plc

A major institutional investor and asset management firm based in the United Kingdom.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Legal & General Group Plc's stake in ResMed Inc. suggests a potential shift in investor sentiment around the medical equipment provider, though the overall institutional ownership remains high. Analysts will likely monitor any further changes in major institutional holdings of ResMed stock.